Foghorn Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '26 Feb 5, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	306	262	272	267	848	721
Market Cap Growth	26.11%	-3.64%	2.10%	-68.56%	17.59%	-
Enterprise Value	149	34	59	-54	807	894
Last Close Price	5.23	4.72	6.45	6.38	22.87	20.27
PS Ratio	13.42	11.61	7.97	13.87	643.15	1677.72
PB Ratio	-	-5.76	-3.53	2381.22	8.76	4.93
P/TBV Ratio	-	-	-	2381.22	8.76	4.93
P/FCF Ratio	-	-	-	1.39	-	-
P/OCF Ratio	-	-	-	1.38	-	-
EV/Sales Ratio	6.06	1.51	1.74	-	612.13	2079.55
Debt / Equity Ratio	-0.25	-0.82	-0.58	459.88	0.60	0.56
Debt / FCF Ratio	-	-	-	0.27	-	-
Asset Turnover	0.10	0.08	0.10	0.04	0.00	0.00
Quick Ratio	2.12	3.64	4.01	6.26	9.33	9.86
Current Ratio	2.16	3.73	4.11	6.37	9.44	10.12
Return on Equity (ROE)	-	-	-	-224.54%	-83.37%	-95.05%
Return on Assets (ROA)	-21.07%	-22.00%	-19.53%	-15.83%	-16.24%	-30.82%
Return on Capital Employed (ROCE)	-72.20%	-46.20%	-47.40%	-33.50%	-21.40%	-28.90%
Earnings Yield	-23.54%	-33.01%	-36.15%	-40.83%	-11.94%	-9.54%
FCF Yield	-29.01%	-38.61%	-43.82%	72.14%	-6.31%	-6.58%
Buyback Yield / Dilution	-26.52%	-30.79%	-0.92%	-11.89%	-236.49%	-163.53%

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q